UBS Upgrades Corteva to Buy, Raises Price Target to $67
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector has upgraded Corteva (NYSE:CTVA) from Neutral to Buy and raised the price target from $63 to $67.
September 05, 2023 | 9:47 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Corteva has been upgraded from Neutral to Buy by UBS, with a raised price target from $63 to $67.
The upgrade from Neutral to Buy indicates a positive outlook for Corteva by UBS. The raised price target suggests that UBS believes the stock is undervalued at its current price and has potential for growth. This could lead to increased investor interest and a potential rise in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100